Kedokteran & Kesehatan editorial
Accelerating Alzheimer’s Therapeutic Development: The Past and Future of Clinical Trials
The core problem
Innovation
Why it matters
Moving forward, the challenge is to develop more efficacious therapies with greater efficiency. The authors propose several strategies:
- **Novel trial designs**: combination therapies, umbrella protocols (testing multiple drugs within one master protocol), and basket protocols (testing one drug across multiple related conditions) to accelerate clinical development.
- **Diversity and inclusivity**: better representation of trial participants is needed; blood-based biomarkers may help improve access for medically underserved groups.
- **Incentivizing innovation**: public-private partnerships, collaborative mechanisms, and new career paths in academia and industry are critical to build momentum.
The authors conclude that these exciting times require sustained collaboration and structural changes to translate scientific progress into effective therapies for Alzheimer’s disease.
Who should read this
Opening member content…